Brief: Aroa Biosurgery Posts FY22 Product Sales Guidance Of $30M-33M
25/05/2021 02:45
May 25 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* FY22 PRODUCT SALES GUIDANCE OF $30M-33M
* TOTAL REVENUE FOR FY21 WAS $22.3M
* NORMALISED LOSS BEFORE INCOME TAX FOR FY21 WAS $7.4M
* PRODUCT GROSS MARGINS EXPECTED TO IMPROVE IN H2 FY22
Source text for Eikon: ID:nASX8V2Yqc
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million